http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019100737-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ce61bf06f294f2f466c067ed41cc8ce |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2019-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b212e81eaa732bf027465f331049108f |
| publicationDate | 2019-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2019100737-A4 |
| titleOfInvention | Anti-Helicobacter Pylori Traditional Chinese Medicine composition and applications |
| abstract | The invention belongs to the technical field of the preparation of Traditional Chinese Medicines, and in particular relates to an anti-HP (Helicobacter Pylori) Traditional Chinese Medicine composition and applications. The Traditional Chinese Medicine composition is obtained by an improvement on the basis of the famous classical prescriptions of Zuojin Pills and Xianglian Pills, and comprises Coptidis Rhizoma extract, Yuhuanglian extract and Phellodenri Chinesis Cortex extract, wherein the content of Yuhuanglian is more than 50% to achieve a good Anti-HP effect; meanwhile, the combination with Tetradium ruticarpum and Aucklandiae Radix effectively eliminates the side effects of a product and improves the safety of the medicine; and the combination of the Traditional Chinese Medicine composition and a clinical standard therapy (a triple therapy) for HP can not only further improve a curative effect, but also repair the intestinal flora disorder caused by the triple therapy and eliminate the side effects of the triple therapy. |
| priorityDate | 2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.